Immunological rationale for PD-1 blockade in intravascular large B-cell lymphoma harboring a PD-L1 structural variant

Blood Immunology & Cellular Therapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles